1. Home
  2. BWAY vs ACV Comparison

BWAY vs ACV Comparison

Compare BWAY & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • ACV
  • Stock Information
  • Founded
  • BWAY 2003
  • ACV 2015
  • Country
  • BWAY Israel
  • ACV United States
  • Employees
  • BWAY N/A
  • ACV N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • ACV Finance/Investors Services
  • Sector
  • BWAY Health Care
  • ACV Finance
  • Exchange
  • BWAY Nasdaq
  • ACV Nasdaq
  • Market Cap
  • BWAY 280.7M
  • ACV 234.1M
  • IPO Year
  • BWAY 2019
  • ACV N/A
  • Fundamental
  • Price
  • BWAY $15.77
  • ACV $23.93
  • Analyst Decision
  • BWAY Strong Buy
  • ACV
  • Analyst Count
  • BWAY 2
  • ACV 0
  • Target Price
  • BWAY $18.00
  • ACV N/A
  • AVG Volume (30 Days)
  • BWAY 79.0K
  • ACV 38.8K
  • Earning Date
  • BWAY 11-11-2025
  • ACV 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • ACV 9.20%
  • EPS Growth
  • BWAY 515.14
  • ACV N/A
  • EPS
  • BWAY 0.11
  • ACV N/A
  • Revenue
  • BWAY $46,084,000.00
  • ACV N/A
  • Revenue This Year
  • BWAY $339.49
  • ACV N/A
  • Revenue Next Year
  • BWAY $21.74
  • ACV N/A
  • P/E Ratio
  • BWAY $54.58
  • ACV N/A
  • Revenue Growth
  • BWAY 26.50
  • ACV N/A
  • 52 Week Low
  • BWAY $7.70
  • ACV $16.82
  • 52 Week High
  • BWAY $16.25
  • ACV $23.74
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 67.06
  • ACV 76.91
  • Support Level
  • BWAY $15.32
  • ACV $23.37
  • Resistance Level
  • BWAY $16.25
  • ACV $24.03
  • Average True Range (ATR)
  • BWAY 0.59
  • ACV 0.22
  • MACD
  • BWAY -0.07
  • ACV 0.09
  • Stochastic Oscillator
  • BWAY 70.25
  • ACV 92.59

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

Share on Social Networks: